Arvinas (ARVN) Cash from Operations (2017 - 2026)

Arvinas (ARVN) recorded quarterly Cash from Operations of 69200000.0 in Q1 2026, down 127.63% quarter-over-quarter from 30400000.0 in Q4 2025, and up 22.16% on a YoY basis from 56647145.49 in Q1 2025.

Arvinas (ARVN) Cash from Operations (2017 - 2026) Analysis & Trends

Arvinas' Cash from Operations history runs 10 years deep, the most recent figure standing at 69200000.0 for Q1 2026.

  • In Q1 2026, Cash from Operations rose 22.16% year-over-year to 69200000.0; the TTM figure through Mar 2026 stood at 254100000.0 (down 1.36% YoY), while the FY2025 annual figure was 273800000.0, down 5.59% from the prior year.
  • Cash from Operations was 69200000.0 for Q1 2026 at Arvinas, down from 30400000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 50300000.0 in Q2 2024 to a low of 128000000.0 in Q3 2024.
  • Historically, Cash from Operations has averaged 71976470.59 across 5 years, with a median of 83100000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 156.71% in 2024, then plunged 289.66% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 71200000.0 in 2022, then decreased by 16.71% to 83100000.0 in 2023, then decreased by 1.2% to 84100000.0 in 2024, then surged by 63.85% to 30400000.0 in 2025, then tumbled by 127.63% to 69200000.0 in 2026.
  • The last three Cash from Operations figures came in at 69200000.0 (Q1 2026), 30400000.0 (Q4 2025), and 59100000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.67 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -12.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -2.49 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.43 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -69.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -69.20 Mn
Mar 31, 2026 -69.20 Mn
Dec 31, 2025 -30.40 Mn
Dec 31, 2025 -30.40 Mn
Sep 30, 2025 -59.10 Mn
Sep 30, 2025 -59.10 Mn
Jun 30, 2025 -95.40 Mn
Jun 30, 2025 -95.40 Mn
Mar 31, 2025 -88.90 Mn
Mar 31, 2025 -88.90 Mn
Dec 31, 2024 -84.10 Mn
Dec 31, 2024 -84.10 Mn
Sep 30, 2024 -128.00 Mn
Sep 30, 2024 -128.00 Mn
Jun 30, 2024 50.30 Mn
Jun 30, 2024 50.30 Mn
Mar 31, 2024 -97.50 Mn
Mar 31, 2024 -97.50 Mn
Dec 31, 2023 -83.10 Mn
Dec 31, 2023 -83.10 Mn